Gene · 729238
SFTPA2: surfactant protein A2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SFTPA2: surfactant protein A2. Genes, record 729238. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/729238
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q8IWL1 | Pulmonary surfactant-associated protein A2 | 248 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents52
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026027383 A | 2026-02-18 | 36 | Q8IWL1 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 65903 | Q8IWL1 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 65904 | Q8IWL1 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 9088 | Q8IWL1 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 12171 | Q8IWL1 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 12172 | Q8IWL1 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 9088 | Q8IWL1 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 12171 | Q8IWL1 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 12172 | Q8IWL1 | Espacenet |
| JP 2025023922 A | 2025-02-19 | 2 | Q8IWL1 | Espacenet |
1 to 10 of 52
See all 52 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,206
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SFTPA2 papers | Newest fiscal year |
|---|---|---|---|
| U19AI125357 | Innate Immunity and Viral Infection in Asthma | 9 | 2025 |
| R01AI052474 | Vaccine Assembly from Surface Proteins of Staphylococcus aureus | 8 | 2025 |
| R01HL095993 | Derivation of lung epithelia from iPS cells for advanced disease modeling | 8 | 2025 |
| P30ES006694 | Southwest Environmental Health Sciences Center | 6 | 2025 |
| P30DK054759 | Precision Medicine Center for Cystic Fibrosis | 5 | 2025 |
| R01HL135062 | Mechanisms of Telomere-Mediated Lung Disease | 5 | 2025 |
| P30ES013508 | Center of Excellence in Environmental Toxicology | 4 | 2025 |
| T32HL094296 | Interdisciplinary Training Program in Lung Research | 4 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 4 | 2025 |
| ZIAAI000904 | Staphylococcal pathogenesis | 4 | 2025 |
1 to 10 of 1,206Source NIH's project files
See all 1,206 nih grantsPapers2,065
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Split aptamer-regulated AuNF nanozymes for colorimetric and electrochemical dual-readout kanamycin biosensing. | Talanta | 2027 | 42580248 | PubTator, text mining | PubMed |
| The phage shock protein A (PspA) maintains membrane potential and supports NADH dehydrogenase function in mycobacteria. | bioRxiv | 2026 | 42818691 | PubTator, text mining | PubMed |
| Plasma Biomarkers of Acute Respiratory Distress Syndrome Vary with Body Size in the Absence of Acute Illness. | medRxiv | 2026 | 42818161 | PubTator, text mining | PubMed |
| Next-Generation Sequencing in Pulmonary Fibrosis: Translational Promise and Current Clinical Limitations. | Curr Issues Mol Biol | 2026 | 42510961 | PubTator, text mining | PubMed |
| A Novel SFTPA2 Variant in a Child with Surfactant Dysfunction-Associated Interstitial Lung Disease. | Indian J Pediatr | 2026 | 42384259 | PubTator, text mining | PubMed |
| A pan-serotype human monoclonal antibody protects against pneumococcal infection by targeting multiple choline binding domain proteins. | bioRxiv | 2026 | 42282568 | PubTator, text mining | PubMed |
| Label-free electrochemical split-aptamer aptasensor with signal amplification via flower-like gold nanostructures for ultrasensitive detection of kanamycin in water. | Talanta | 2026 | 42172966 | PubTator, text mining | PubMed |
| Membrane interaction of cyanobacterial and chloroplast ESCRT-III proteins. | Plant J | 2026 | 41937622 | PubTator, text mining | PubMed |
| Rapid but Transient Microevolution with Minimal Recombination During High-Transmission Streptococcus pneumoniae Carriage in a Day-Care Cohort. | Microb Drug Resist | 2026 | 41925144 | PubTator, text mining | PubMed |
| Targeting the epithelium in pulmonary fibrosis. | Eur Respir Rev | 2026 | 41881452 | PubTator, text mining | PubMed |
1 to 10 of 2,065
See all 2,065 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/729238
GET https://conductscience.org/api/genes/v1/729238/patents?page=2